929 related articles for article (PubMed ID: 28241846)
41. Modulatory effects of adiponectin on the polarization of tumor-associated macrophages.
Peng J; Tsang JY; Ho DH; Zhang R; Xiao H; Li D; Zhu J; Wang F; Bian Z; Lui VC; Xu A; Tam PK; Lamb JR; Xia H; Chen Y
Int J Cancer; 2015 Aug; 137(4):848-58. PubMed ID: 25694398
[TBL] [Abstract][Full Text] [Related]
42. Phagocytes as Corrupted Policemen in Cancer-Related Inflammation.
Bonavita E; Galdiero MR; Jaillon S; Mantovani A
Adv Cancer Res; 2015; 128():141-71. PubMed ID: 26216632
[TBL] [Abstract][Full Text] [Related]
43. Tumor-associated macrophages: Potential therapeutic targets and diagnostic markers in cancer.
Song J; Xiao T; Li M; Jia Q
Pathol Res Pract; 2023 Sep; 249():154739. PubMed ID: 37544129
[TBL] [Abstract][Full Text] [Related]
44. Type 2 Endometrial Cancer is Associated With a High Density of Tumor-Associated Macrophages in the Stromal Compartment.
Kelly MG; Francisco AM; Cimic A; Wofford A; Fitzgerald NC; Yu J; Taylor RN
Reprod Sci; 2015 Aug; 22(8):948-53. PubMed ID: 25701837
[TBL] [Abstract][Full Text] [Related]
45. The contribution of tumor-associated macrophages in glioma neo-angiogenesis and implications for anti-angiogenic strategies.
Zhu C; Kros JM; Cheng C; Mustafa D
Neuro Oncol; 2017 Oct; 19(11):1435-1446. PubMed ID: 28575312
[TBL] [Abstract][Full Text] [Related]
46. Antitumor strategies targeting macrophages: the importance of considering the differences in differentiation/polarization processes between human and mouse macrophages.
Monnier M; Paolini L; Vinatier E; Mantovani A; Delneste Y; Jeannin P
J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36270732
[TBL] [Abstract][Full Text] [Related]
47. The Fate of the Tumor in the Hands of Microenvironment: Role of TAMs and mTOR Pathway.
Soave DF; Miguel MP; Tomé FD; de Menezes LB; Nagib PR; Celes MR
Mediators Inflamm; 2016; 2016():8910520. PubMed ID: 28074082
[TBL] [Abstract][Full Text] [Related]
48. Novel insights in the regulation and function of macrophages in the tumor microenvironment.
Bolli E; Movahedi K; Laoui D; Van Ginderachter JA
Curr Opin Oncol; 2017 Jan; 29(1):55-61. PubMed ID: 27792052
[TBL] [Abstract][Full Text] [Related]
49. Tumor-associated macrophages in breast cancer.
Leek RD; Harris AL
J Mammary Gland Biol Neoplasia; 2002 Apr; 7(2):177-89. PubMed ID: 12463738
[TBL] [Abstract][Full Text] [Related]
50. Pathophysiology of tumor-associated macrophages.
Yuan A; Chen JJ; Yang PC
Adv Clin Chem; 2008; 45():199-223. PubMed ID: 18429498
[TBL] [Abstract][Full Text] [Related]
51. Tumor-associated macrophages in lymphoma: From mechanisms to therapy.
Xiong X; Xie X; Wang Z; Zhang Y; Wang L
Int Immunopharmacol; 2022 Nov; 112():109235. PubMed ID: 36215869
[TBL] [Abstract][Full Text] [Related]
52. Influence of the Hippo-YAP signalling pathway on tumor associated macrophages (TAMs) and its implications on cancer immunosuppressive microenvironment.
Yang W; Yang S; Zhang F; Cheng F; Wang X; Rao J
Ann Transl Med; 2020 Mar; 8(6):399. PubMed ID: 32355843
[TBL] [Abstract][Full Text] [Related]
53. Synthesis and evaluation of multivalent M2pep peptides for targeting alternatively activated M2 macrophages.
Ngambenjawong C; Cieslewicz M; Schellinger JG; Pun SH
J Control Release; 2016 Feb; 224():103-111. PubMed ID: 26772876
[TBL] [Abstract][Full Text] [Related]
54. Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy.
Komohara Y; Fujiwara Y; Ohnishi K; Takeya M
Adv Drug Deliv Rev; 2016 Apr; 99(Pt B):180-185. PubMed ID: 26621196
[TBL] [Abstract][Full Text] [Related]
55. Targeting tumor associated macrophages (TAMs) via nanocarriers.
Singh Y; Pawar VK; Meher JG; Raval K; Kumar A; Shrivastava R; Bhadauria S; Chourasia MK
J Control Release; 2017 May; 254():92-106. PubMed ID: 28377038
[TBL] [Abstract][Full Text] [Related]
56. Tumor Associated Macrophages in Kidney Cancer.
Kovaleva OV; Samoilova DV; Shitova MS; Gratchev A
Anal Cell Pathol (Amst); 2016; 2016():9307549. PubMed ID: 27807511
[TBL] [Abstract][Full Text] [Related]
57. Alternative activation of tumor-associated macrophages by IL-4: priming for protumoral functions.
Wang HW; Joyce JA
Cell Cycle; 2010 Dec; 9(24):4824-35. PubMed ID: 21150330
[TBL] [Abstract][Full Text] [Related]
58. The Role of Tumor-Associated Macrophages in Leukemia.
Li Y; You MJ; Yang Y; Hu D; Tian C
Acta Haematol; 2020; 143(2):112-117. PubMed ID: 31288222
[TBL] [Abstract][Full Text] [Related]
59. Activin A Sustains the Metastatic Phenotype of Tumor-Associated Macrophages and Is a Prognostic Marker in Human Cutaneous Melanoma.
Gutiérrez-Seijo A; García-Martínez E; Barrio-Alonso C; Parra-Blanco V; Avilés-Izquierdo JA; Sánchez-Mateos P; Samaniego R
J Invest Dermatol; 2022 Mar; 142(3 Pt A):653-661.e2. PubMed ID: 34499901
[TBL] [Abstract][Full Text] [Related]
60. Regulation of epithelial-mesenchymal transition by tumor-associated macrophages in cancer.
Zhang J; Yao H; Song G; Liao X; Xian Y; Li W
Am J Transl Res; 2015; 7(10):1699-711. PubMed ID: 26692918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
